Abstract: A microbial method for the preparation of an epothilone containing a terminal hydroxyalkyl group, comprising contacting at least one epothilone having a terminal alkyl group with an enzyme or microorganism capable of catalyzing the selective hydroxylation of said alkyl group to a hydroxyalkyl group, and effecting said hydroxylation.
Type:
Grant
Filed:
December 21, 1999
Date of Patent:
August 24, 2004
Assignee:
Bristol-Myers Squibb Company
Inventors:
Wenying Li, James A. Matson, Xiaohua Huang, Kin Sing Lam, Grace A. McClure
Abstract: The present invention relates to 12,13-position modified epothilone derivatives, methods of preparation of the derivatives and intermediates therefor.
Type:
Grant
Filed:
March 29, 1999
Date of Patent:
April 30, 2002
Assignee:
Bristol-Myers Squibb Company
Inventors:
Gregory D. Vite, Soong-Hoon Kim, Gerhard Höfle